To compare the Safety and Efficacy of Repeated GnRH agonist injections versus rescue hCG for modified Luteal Phase Support in predicted hyper-responders undergoing IVF cycles: A randomized controlled trial - NI

A0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•Predicted hyper-responders: fulfilling either of the three criteria, a. AFC more than 16,b. more than 13 follicles of more than 11 mm on day of GnRH agonist trigger, c.Serum estradiol levels more than 3500 pg per ml on day of trigger
•GnRH antagonist cycles
•Women aged 22 to less than 40 years
•Unexplained infertility
•Anovulatory infertility
•Mild to moderate male factor infertility

•more than 25 oocytes retrieved at ovum pick up
•Signs of early onset OHSS
•Any other contraindication to fresh ET
•Known reasons for impaired implantation (i.e. hydrosalpinx, fibroid distorting the endometrial cavity, Asherman’s syndrome, thrombophilia or endometrial tuberculosis)
•Previous 2 or more failed IVF
•Patients who do not give written informed consent to participate
•BMI less than 18 or more than 30Kg per m2
•Cycles with frozen spermatozoa or oocytes
•Oocyte donation cycles
•Uterine anomalies

发起方